Oncovin and pancytopenia Patient Reports February 12, 2012



Oncovin Side Effects Report #4692345-5
Oncovin side effect was reported by a Physician from on May 30, 2005. Female patient, 77 years of age, weighting 158.7 lb, was diagnosed with malignant melanoma and was treated with Oncovin. After drug was administered, patient experienced the following side effects: disease recurrence, histiocytosis haematophagic, lymphangitis, myelodysplastic syndrome, pancytopenia. Oncovin dosage: 1 MG OTHER. During the same period patient was treated with DACARBAZINE, NIDRAN, FERON. Patient was hospitalized. Patient recovered.

Oncovin Side Effects Report #5225278-6
Oncovin side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. Oncovin dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.

Oncovin Side Effects Report #5417778-0
Oncovin side effect was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. Oncovin dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Oncovin